In addition, our study showed the expression of MSH6, MLH1 and PMS2 gene exerted positive influences on OS of late-stage and poor-differentiated ovarian cancer patients, but not of early stage and well-differentiated ovarian cancer patients. The gene discussed is MSH6; the disease is ovarian carcinoma.